0001209191-19-021091.txt : 20190322 0001209191-19-021091.hdr.sgml : 20190322 20190322194121 ACCESSION NUMBER: 0001209191-19-021091 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190206 FILED AS OF DATE: 20190322 DATE AS OF CHANGE: 20190322 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cohen Fred E CENTRAL INDEX KEY: 0001339358 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38079 FILM NUMBER: 19701116 MAIL ADDRESS: STREET 1: 301 COMMERCE STREET STREET 2: SUITE 3300 CITY: FORT WORTH STATE: TX ZIP: 76102 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: UroGen Pharma Ltd. CENTRAL INDEX KEY: 0001668243 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9 HA'TA'ASIYA ST CITY: RA'ANANA STATE: L3 ZIP: 4365007 BUSINESS PHONE: 972 9 770 7601 MAIL ADDRESS: STREET 1: 9 HA'TA'ASIYA ST CITY: RA'ANANA STATE: L3 ZIP: 4365007 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-02-06 0 0001668243 UroGen Pharma Ltd. URGN 0001339358 Cohen Fred E C/O UROGEN PHARMA LTD. 9 HA?TA?ASIYA STREET RA?ANANA L3 4365007 ISRAEL 1 0 0 0 Ordinary Shares 2019-02-06 4 M 0 15000 16.99 A 15000 D Stock Option (Right to Buy) 16.99 2019-02-06 4 M 0 15000 0.00 D 2027-05-15 Ordinary Shares 15000 25000 D 6.25% of the ordinary shares underlying the stock option vested on each of August 15, 2017, November 15, 2017 and February 15, 2018; 31.25% of the shares vested on May 15, 2018, and the remaining shares vest in 8 equal quarterly installments thereafter. /s/ Peter Pfreundschuh, Attorney-in-Fact 2019-03-20